WebDoctor Encyclopedia

Soft-tissue sarcomas

Clear cell sarcoma of soft tissue

Clear cell sarcoma is a rare soft-tissue cancer of young adults that grows from tendons, mostly in the foot, ankle or knee. It looks like melanoma under the microscope but has its own gene fusion.

Medically reviewed Last reviewed October 17, 2026

What is clear cell sarcoma of soft tissue?

Clear cell sarcoma is a rare cancer of the soft tissues. It usually grows from a tendon or the tough sheets of tissue (aponeuroses) around it, most often in the foot, ankle or around the knee.

It mainly affects young adults, typically between 20 and 40. The first sign is often a small, slow-growing lump that may be present for months or years before it is checked.

Under the microscope, the cancer cells often look pale or “clear” and make the same proteins as pigment cells (melanocytes). For this reason it was once called “malignant melanoma of soft parts”.

It is not a skin melanoma, however. Almost every clear cell sarcoma carries a specific gene fusion, EWSR1::ATF1, which skin melanoma does not have.

Unlike most sarcomas, clear cell sarcoma often spreads to lymph nodes, as well as to the lungs. The main treatment is wide surgery, sometimes with radiotherapy. Drug treatments for advanced disease work less well than for many other cancers, so clinical trials are important.

1. Key facts at a glance

Feature Details
Type of cancer Soft-tissue sarcoma with melanocytic features
How common Under 1% of soft-tissue sarcomas
Typical age Mostly 20-40; uncommon in children and older adults
Sex Men and women are affected about equally
Main sites Foot and ankle, knee, thigh, hand and wrist; usually deep, attached to tendons
Key gene change EWSR1::ATF1 fusion in over 90%; EWSR1::CREB1 in a minority
Spread Lymph nodes and lungs; also bone and liver
Main treatments Wide surgery, radiotherapy, lymph node surgery if needed; drugs and trials for advanced disease
Outlook About 50-65% alive at 5 years overall; much better for small tumours without spread

2. Clear cell sarcoma and similar tumours

Several different tumours share the name “clear cell” or look similar. They are separate diseases.

Tumour How it differs
Clear cell sarcoma of soft tissue Deep tumour of tendons in young adults; EWSR1::ATF1 fusion
Skin (cutaneous) melanoma Starts in the skin, often from a mole; has BRAF, NRAS or other mutations, not EWSR1 fusions
Malignant gastrointestinal neuroectodermal tumour Previously called clear cell sarcoma-like tumour of the gut; grows in the bowel wall; often EWSR1::CREB1
Clear cell sarcoma of the kidney A childhood kidney cancer with BCOR or YWHAE changes; not related
Clear cell renal cell carcinoma The commonest adult kidney cancer; not a sarcoma

3. Causes and risk factors

The cause of clear cell sarcoma is not known. It is not caused by sun exposure, injury or lifestyle.

Factor Notes
EWSR1::ATF1 fusion A swap between chromosomes 12 and 22, t(12;22), inside the tumour cells. The fusion protein switches on genes normally used by pigment cells, such as MITF
EWSR1::CREB1 fusion A related fusion, t(2;22), found in a small group of cases
Inherited risk No inherited syndrome is linked to it; it is not passed on in families
Previous injury People often remember a knock to the area, but this is thought to draw attention to the lump rather than cause it

4. How does it look?

4.1 On the body

Feature What it looks or feels like
Lump A firm, rubbery lump deep under the skin, often 2-5 cm across, near the heel, ankle, knee or wrist
Growth Usually slow; may stay small for a long time
Skin Normal over the lump; it does not usually look dark like a melanoma
Attachment Often feels fixed to a tendon and may move a little when the tendon moves
Lymph nodes Swollen glands behind the knee or in the groin or armpit if it has spread

4.2 On scans

Test Typical findings
Ultrasound A solid, well-defined mass next to a tendon, often with blood flow
MRI The main test; shows a lobulated mass, sometimes slightly bright on T1 images because of melanin, and enhancing after contrast
CT chest Looks for spread to the lungs
PET-CT Helps check the lymph nodes and other sites of spread

4.3 Under the microscope

Feature What the pathologist sees
Pattern Nests and bundles of cells separated by thin fibrous bands
Cells Round or spindle-shaped cells with pale or clear cytoplasm and prominent nucleoli
Giant cells Wreath-like giant cells with several nuclei are common
Pigment Melanin pigment is seen in some tumours
Stains Positive for S100, SOX10, HMB-45 and Melan-A, like melanoma
Genetic test FISH, RT-PCR or sequencing shows EWSR1 rearrangement with ATF1 or CREB1; this separates it from melanoma

5. Symptoms

Many people have no symptoms other than a lump. Because it can grow slowly, it is often mistaken for a ganglion, a cyst or a sports injury.

5.1 Common symptoms

Symptom Notes
Painless lump The most common first sign, often in the foot, ankle or around the knee
Pain or tenderness Present in some people, especially with walking or pressure from shoes
Stiffness Reduced movement of a nearby joint or tendon
Numbness or tingling If the tumour presses on a nerve
A lump that comes back After it was removed as a “benign” lump without a full diagnosis

5.2 Symptoms of spread

Area Possible symptoms
Lymph nodes Firm, painless swelling in the groin, behind the knee or in the armpit
Lungs Cough or breathlessness, often only late
Bone Bone pain
Liver Pain under the right ribs, loss of appetite
General Tiredness and weight loss in advanced disease

5.3 When to see a doctor

Ask for a medical review if a lump:

  • Is deep or attached to a tendon
  • Is larger than about 5 cm, or keeps getting bigger
  • Is painful or limits movement
  • Comes back after removal

These features do not mean cancer, but they are reasons for an MRI scan and a referral to a sarcoma centre before any operation.

6. Diagnosis

The diagnosis should be made at a specialist sarcoma centre, because clear cell sarcoma is easy to confuse with melanoma and with benign lumps.

Test Why it is done
MRI of the lump Shows size, depth and the relation to tendons, nerves and vessels
Core needle biopsy Provides tissue for microscopy, stains and genetic tests; planned so the track can be removed later
Fusion testing Confirms EWSR1::ATF1 or EWSR1::CREB1 and separates the tumour from melanoma
Skin examination Rules out a skin melanoma that could have spread
CT chest Looks for lung spread
Lymph node assessment Ultrasound or PET-CT; sentinel lymph node biopsy is used in some centres
Blood tests General health before treatment

Staging

Clear cell sarcoma is staged with the AJCC/UICC TNM system for soft-tissue sarcoma. This looks at tumour size (T), lymph node spread (N) and distant spread (M), along with tumour grade. Clear cell sarcoma is treated as a high-grade sarcoma.

7. Treatment

7.1 Localised disease

Treatment What it involves Notes
Wide surgical excision Removal of the tumour with a margin of healthy tissue The main and most important treatment; may need tendon repair or reconstruction
Amputation Removal of part of the foot, hand or limb Rarely needed today; used when wide surgery would leave a useless limb
Radiotherapy Given before or after surgery Lowers the chance of the tumour coming back locally, especially for large tumours or close margins
Lymph node surgery Removal of affected lymph nodes Done when nodes contain cancer; sentinel node biopsy may be offered
Chemotherapy Doxorubicin-based drugs Not routinely given for localised disease, because benefit is uncertain

7.2 Advanced or recurrent disease

Option Notes
Surgery for isolated spread Removal of a single lung spot or a lymph node recurrence can give long control in selected people
Chemotherapy Doxorubicin, ifosfamide or other sarcoma drugs; responses are uncommon and usually short
Targeted drugs Drugs such as crizotinib or sunitinib (acting on MET and other pathways) have been tried, with small benefit in some patients
Immunotherapy Immune checkpoint drugs such as pembrolizumab, nivolumab or ipilimumab have produced occasional lasting responses
Radiotherapy Relieves pain or controls a single troublesome site
Clinical trials Strongly recommended, because no standard drug works well

8. Side effects of treatment

Treatment Possible effects What helps
Surgery on foot or hand Pain, stiffness, wound problems, change in walking or grip Physiotherapy, orthotics, hand therapy
Radiotherapy Skin redness, wound healing problems (especially before surgery), later stiffness and swelling Skin care, stretching, lymphoedema advice
Lymph node removal Swelling of the limb (lymphoedema) Compression garments, specialist therapy
Chemotherapy Tiredness, hair loss, infections, nausea Supportive medicines, blood tests
Immunotherapy Inflammation of the skin, gut, liver, lungs or hormone glands Early reporting, steroids if needed

9. Outlook

Clear cell sarcoma can come back many years after treatment, so follow-up is long.

Situation What to expect
Small tumour (under 5 cm), fully removed, no spread Good chance of long-term cure
Large tumour or close margins Higher risk of recurrence in the same area and of later spread
Lymph node spread Worse outlook, but some people are cured with surgery and radiotherapy
Distant spread Usually not curable; survival is often counted in months to a few years, though some live longer
Overall Roughly 50-65% of people are alive 5 years after diagnosis

The most important factors are tumour size, depth, necrosis and whether it has spread at diagnosis.

10. Follow-up and living with clear cell sarcoma

Time after treatment Typical follow-up
Years 1-3 Examination, MRI of the treated site and chest imaging every 3-4 months
Years 4-5 Every 6 months
After 5 years Yearly, often for 10 years, because late recurrence happens

Report any new lump, swelling of lymph nodes or a cough that does not settle.

After foot or hand surgery, rehabilitation helps people return to walking, sport and work. Patient groups for sarcoma offer support and information for this rare cancer.

11. Frequently asked questions

Question Answer
Is this a type of melanoma? No. It looks like melanoma under the microscope, but it is a sarcoma with its own gene fusion and is treated as a sarcoma
Did the sun cause it? No. It grows deep in the body and is not linked to sun exposure
Why check my lymph nodes? Clear cell sarcoma spreads to nodes much more often than other sarcomas
Will I lose my foot? Most people keep their limb. Amputation is only considered when the tumour cannot be removed otherwise
Can I play sport again? Many people can, after healing and rehabilitation, depending on the surgery

12. Questions to ask your care team

  • Has my tumour been tested for the EWSR1 fusion, and has a sarcoma pathologist reviewed it?
  • How big is the tumour, how deep is it, and has it reached any lymph nodes?
  • Will I need radiotherapy, and would it be given before or after surgery?
  • What will surgery mean for walking, grip, work and sport?
  • Should my lymph nodes be checked with a sentinel node biopsy?
  • How often will I have scans, and for how many years?
  • Are there clinical trials I could join now or if the cancer returns?

Writing questions down before each appointment, and bringing someone with you, makes it easier to remember the answers. Your specialist nurse is usually the best first contact between visits.

Resources

  1. WHO Classification of Tumours Editorial Board (2020) Soft Tissue and Bone Tumours. 5th edn. Lyon: International Agency for Research on Cancer.
  2. Enzinger, F.M. (1965) ‘Clear-cell sarcoma of tendons and aponeuroses. An analysis of 21 cases’, Cancer, 18, pp. 1163-1174.
  3. Chung, E.B. and Enzinger, F.M. (1983) ‘Malignant melanoma of soft parts. A reassessment of clear cell sarcoma’, American Journal of Surgical Pathology, 7(5), pp. 405-413.
  4. Hisaoka, M. et al. (2008) ‘Clear cell sarcoma of soft tissue: a clinicopathologic, immunohistochemical, and molecular analysis of 33 cases’, American Journal of Surgical Pathology, 32(3), pp. 452-460.
  5. Takemori, T. et al. (2024) ‘Clear cell sarcoma in Japan: an analysis of the population-based cancer registry in Japan’, Japanese Journal of Clinical Oncology, 54(12), pp. 1281-1287.
  6. Smrke, A. et al. (2022) ‘Systemic treatment of advanced clear cell sarcoma: results from a retrospective international series from the World Sarcoma Network’, ESMO Open, 7(3), 100522.
  7. Gronchi, A. et al. (2021) ‘Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up’, Annals of Oncology, 32(11), pp. 1348-1365.
  8. National Cancer Institute (2026) Adult Soft Tissue Sarcoma Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/soft-tissue-sarcoma/hp/adult-soft-tissue-treatment-pdq (Accessed: October 2026).

Prepared by the editorial team, October 2026.